Related Experiment Video
Updated: Dec 11, 2025

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
Abstract:
The Research to Accelerate Cures and Equity for Children Act recently went into effect, potentially paving the way for more drug development in pediatric cancers. The legislation will tighten the requirements for testing cancer agents used in adults to treat malignancies in children when there is a shared molecular target.
Insights
New legislation may accelerate pediatric cancer drug development. The Research to Accelerate Cures and Equity for Children Act enhances requirements for testing adult cancer drugs in children with shared molecular targets.
Area of Science:
- Oncology
- Pediatric Medicine
- Pharmacology
Background:
- Pediatric cancers represent a significant unmet medical need.
- Drug development for rare pediatric malignancies often lags behind adult cancer research.
- Existing legislation has not sufficiently incentivized pediatric cancer drug testing.
More Related Videos
10:49Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
09:29Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood
Published on: February 1, 2013
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Treatment Resistant Cancers
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Prevention
Some...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...